A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 109,816 shares of HOWL stock, worth $179,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109,816
Previous 319,477 65.63%
Holding current value
$179,000
Previous $779,000 70.22%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.71 - $2.95 $358,520 - $618,499
-209,661 Reduced 65.63%
109,816 $232,000
Q2 2024

Aug 14, 2024

BUY
$2.34 - $6.75 $747,576 - $2.16 Million
319,477 New
319,477 $779,000

Others Institutions Holding HOWL

About Werewolf Therapeutics, Inc.


  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $48.1M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.